vTv Therapeutics Inc. - (VTVT): Price and Financial Metrics
GET POWR RATINGS... FREE!
VTVT POWR Grades
- VTVT scores best on the Growth dimension, with a Growth rank ahead of 78.72% of US stocks.
- VTVT's strongest trending metric is Momentum; it's been moving down over the last 31 weeks.
- VTVT ranks lowest in Stability; there it ranks in the 3rd percentile.
VTVT Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for VTVT is -0.13 -- better than only 6.33% of US stocks.
- With a year-over-year growth in debt of -85.11%, vTv Therapeutics Inc's debt growth rate surpasses just 2.64% of about US stocks.
- As for revenue growth, note that VTVT's revenue has grown 299.41% over the past 12 months; that beats the revenue growth of 97.66% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to vTv Therapeutics Inc, a group of peers worth examining would be IDYA, MARK, KIQ, ARPO, and LPTX.
- Visit VTVT's SEC page to see the company's official filings. To visit the company's web site, go to www.vtvtherapeutics.com.
VTVT Stock Price Chart Interactive Chart >
VTVT Price/Volume Stats
|Current price||$2.68||52-week high||$4.75|
|Prev. close||$2.67||52-week low||$1.44|
|Day high||$2.88||Avg. volume||4,884,301|
|50-day MA||$2.56||Dividend yield||N/A|
|200-day MA||$2.24||Market Cap||217.37M|
vTv Therapeutics Inc. - (VTVT) Company Bio
vTv Therapeutics Inc., a biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company was founded in 2015 and is based in High Point, North Carolina.
VTVT Latest News Stream
|Loading, please wait...|
VTVT Latest Social Stream
View Full VTVT Social Stream
Latest VTVT News From Around the Web
Below are the latest news stories about vTv Therapeutics Inc that investors may wish to consider to help them evaluate VTVT as an investment opportunity.
Los Angeles, USA, May 31, 2021 (GLOBE NEWSWIRE) -- Alzheimer's Disease Pipeline Report: Current Therapies, Emerging Drugs, and Treatment Outlook Alzheimer's Disease pipeline shows progress in the clinical trials with the upcoming therapies such as BAN2401, Gantenerumab, Bryostatin-1, INB03, AZT-211, and others. DelveInsight's " Alzheimer's Disease Pipeline Insight " report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in the Alzheimer's Disease pipeline landscapes. It comprises Alzheimer's Disease pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Alzheimer's Disease therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Alzheimer's Disease...
The big shareholder groups in vTv Therapeutics Inc. ( NASDAQ:VTVT ) have power over the company. Large companies...
vTv Therapeutics, Arrival, PubMatic, and Schrodinger are four up-and-coming stocks to buy.
The weekend is almost here but investors have one more day of trading and we're helping out with the biggest pre-market movers for Friday.
Today, VTVT stock is on the move as investors price in a key announcement from the FDA designating a leading drug a breakthrough therapy.
VTVT Price Returns